Long-term follow-up for people treated with Senza5 CART5
This study follows participants who have already received an experimental immune cell therapy called Senza5 CART5, to check their health over a longer period of time. It helps researchers learn more about the long-term effects and safety of this treatment.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You must agree to take part by signing a consent form (or have a parent or guardian sign if you are a minor).
- You must have already received the Senza5 CART5 treatment in a previous Vittoria BioTherapeutics clinical trial.
- You must be willing to follow the study rules and come to follow-up visits.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study checks how people do over the long term after receiving CAR-T, an advanced immune treatment. It may help doctors understand long-term safety and benefits, and what to expect after treatment.
This trial tests a new CAR T-cell treatment for T-cell lymphoma that has come back or hasn't responded to standard treatments. The treatment is designed to target cancer cells that have a protein called CD5 on their surface.
This study checks your health over time after you previously received gene-modified cell therapy in a Sorrento-sponsored trial. It helps researchers understand long-term safety and outcomes and may lead to better care for future patients.
This study checks how people do over the long run after receiving a personalized, genetically modified CAR T cell treatment. It may help researchers understand long-term safety and outcomes, which can improve future care.
This study is a long-term follow-up for people who have already received the GF-CART01 treatment in a previous study. It checks how safe the treatment stays over time and how long the effects last.
This study monitors participants who received a certain type of CAR T-cell therapy for cancer. It helps researchers understand long-term effects and safety.
Hear when a new Participants Treated With Senza5 trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.